Role of maltol in advanced glycation end products and free radicals: In-vitro and in-vivo studies

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 4, 2008, Pages 445-452

  Ki, Sung Kang ^a   Yamabe, Noriko ^a   Hyun, Young Kim ^a   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOGUANIDINE; FREE RADICAL; GLYCOSYLATED PROTEIN; MALTOL; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG URINE LEVEL; GLYCATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; SYMPTOMATOLOGY;

ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FREE RADICALS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; LYSINE; MALE; PROTEINURIA; PYRONES; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA;

EID: 41849131845     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.4.0006     Document Type: Article

References (36)

1. Ahmed, N. (2005) Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21
2. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412
3. Bjeldanes, L. F., Chew, H. (1979) Mutagenicity of 1,2-dicarbonyl compounds: maltol, kojic acid, diacetyl and related substances. Mutat. Res. 67: 367-371
4. Courderot-Masuyer, C., Dalloz, F., Maupoil, V., Rochette, L. (1999) Antioxidant properties of aminoguanidine. Fundam. Clin. Pharmacol. 13: 535-540
5. Davidek, T., Clety, N., Devaud, S., Robert, F., Blank, I. (2003) Simultaneous quantitative analysis of Maillard reaction precursors and products by high-performance anion exchange chromatography. J. Agric. Food Chem. 51: 7259-7265
6. Evans, J. L., Goldfine, I. D., Maddux, B. A., Grodsky, G. M. (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23: 599-622
7. Fluckiger, R., Winterhalter, K. H. (1976) In vitro synthesis of hemoglobin AIc. FEBS Lett. 71: 356-360
8. Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., Kurokawa, K. (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin. Invest. 100: 2995-3004
9. Huang, D., Ou, B., Prior, R. L. (2005) The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 53: 1841-1856
10. Huang, Y., Lin, S., Zhou, J. (1998) Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue. Chin. Med. J. 111: 698-704
11. Itzhaki, R. F., Gill, D. M. (1964) A micro-biuret method for estimating proteins. Anal. Biochem. 9: 401-410
12. Jang, D. S., Kim, J. M., Lee, Y. M., Kim, Y. S., Kim, J. H., Kim, J. S. (2006) Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54: 1315-1317
13. Johnson, R. R., Alford, E. D., Kinzer, G. W. (1969) Formation of sucrose pyrolysis products. J. Agric. Food Chem. 17: 22-24
14. Kang, K. S., Kim, H. Y., Pyo, J. S., Yokozawa, T. (2006a) Increase in the free radical scavenging activity of ginseng by heat-processing. Biol. Pharm. Bull. 29: 750-754
15. Kang, K. S., Kim, H. Y., Yamabe, N., Nagai, R., Yokozawa, T. (2006b) Protective effect of sun ginseng against diabetic renal damage. Biol. Pharm. Bull. 29: 1678-1684
16. Kedziora-Kornatowska, K., Luciak, M. (1998) Effect of aminoguanidine on lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney. Biochem. Mol. Biol. Int. 46: 577-583
17. Kim, Y. B., Oh, S. H., Sok, D. E., Kim, M. R. (2004) Neuroprotective effect of maltol against oxidative stress in brain of mice challenged with kainic acid. Nutr. Neurosci. 7: 33-39
18. Levin, A. (2001) Identification of patients and risk factors in chronic kidney disease-evaluating risk factors and therapeutic strategies. Nephrol. Dial. Transplant. 16: 57-60
19. Naito, C., Yamanaka, T. (1978) Lipid peroxides in atherosclerotic diseases. Jpn. J. Geriat. 15: 187-191
20. Nakayama, H., Mitsuhashi, T., Kuwajima, S., Aoki, S., Kuroda, Y., Itoh, T., Nakagawa, S. (1993) Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat. Diabetes 42: 345-350
21. Price, D. L., Rhett, P. M., Thorpe, S. R., Baynes, J. W. (2001) Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 276: 48967-48972
22. 3 structural isomers. Inorg. Chem. 44: 2689-2697
23. Sakagishi, Y. (1968) Total protein. In: Saito, M., Kitamura, M., Niwa, M. (eds) Rinsho Kagaku Bunseki II. Tokyo Kagaku Dojin, Tokyo, pp 115-142
24. Schrijvers, B. F., Vriese, A. S. D., Flyvbjerg, A. (2004) From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 25: 971-1010
25. Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., Jerums, G. (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40: 1328-1334
26. Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., Makino, H. (1999) Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumor necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42: 878-886
27. Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K., Lee, S. S. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481: 243-268
28. Tabatabaie, T., Kotake, Y., Wallis, G., Jacob, J. M., Floyd, R. A. (1997) Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus. FEBS Lett. 407: 148-152
29. Thompson, K. H., Chiles, J., Yuen, V. G., Tse, J., McNeill, J. H., Orvig, C. (2004) Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. J. Inorg. Biochem. 98: 683-690
30. Vinson, J. A., Howard, T. B. (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7: 659-663
31. Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., Steffes, M. (1994) Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc. Natl Acad. Sci. USA 91: 11704-11708
32. Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D'Agati, V., Schmidt, A. M. (2003) Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J. Am. Soc. Nephrol. 14: 1383-1395
33. Williams, M. E. (2003) New therapies for advanced glycation end product nephrotoxicity: current challenges. Am. J. Kidney Dis. 41: S42-S47
34. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269: 9889-9897
35. Yasumoto, E., Nakano, K., Nakayachi, T., Morshed, S. R., Hashimoto, K., Kikuchi, H., Nishikawa, H., Kawase, M., Sakagami, H. (2004) Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines. Anticancer Res. 24: 755-762
36. Yuen, V. G., Caravan, P., Gelmini, L., Glover, N., McNeill, J. H., Setyawati, I. A., Zhou, Y., Orvig, C. (1997) Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. J. Inorg. Biochem. 68: 109-116